ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $699,862 | +5.8% | 25,787 | +19.8% | 0.46% | +22.1% |
| Q2 2023 | $661,524 | +150.0% | 21,520 | +193.0% | 0.38% | +132.1% |
| Q1 2023 | $264,635 | +24.7% | 7,345 | +36.8% | 0.16% | +7.3% |
| Q4 2022 | $212,219 | -6.9% | 5,370 | -5.3% | 0.15% | -20.5% |
| Q3 2022 | $228,000 | -8.8% | 5,672 | -4.6% | 0.19% | -3.6% |
| Q2 2022 | $250,000 | -65.8% | 5,948 | -68.4% | 0.20% | -59.0% |
| Q1 2022 | $732,000 | -3.6% | 18,800 | -1.3% | 0.48% | -0.2% |
| Q4 2021 | $759,000 | +13.5% | 19,049 | +2.9% | 0.48% | +6.2% |
| Q3 2021 | $669,000 | +4.4% | 18,506 | +18.3% | 0.45% | +10.2% |
| Q2 2021 | $641,000 | +170.5% | 15,646 | +188.5% | 0.41% | +183.4% |
| Q1 2021 | $237,000 | – | 5,423 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |